Increase in bacterial resistance to antibiotics during the COVID-19 pandemic: A narrative review
DOI:
https://doi.org/10.33448/rsd-v13i6.46040Keywords:
Antibiotics; Azithromycin; COVID-19; Global health.Abstract
COVID-19, caused by the SARS-CoV-2 virus, led to the excessive use of antibiotics worldwide. Despite being ineffective against viruses, antibiotics were widely used to prevent or treat the disease and its associated secondary infections. However, the excessive and inappropriate use of these medications can lead to the development of bacterial resistance, a global health problem that makes antibiotics ineffective against bacterial infections. The most prescribed drug by healthcare professionals during the pandemic was azithromycin, a macrolide widely used for bacterial infections, but in cases of COVID-19, it was indicated to alleviate the symptoms of the disease, resulting in an increase in bacterial resistance to the drug. The central question addressed in this study is: "How did the use of antibiotics to combat COVID-19 influence the increase in bacterial resistance to these medications, and how is this reflected after the end of the pandemic?" This research aims to contribute to a better understanding of the consequences of the excessive use of antibiotics during pandemics similar to COVID-19. This study aims to evaluate the increase in bacterial resistance to antibiotics used during the pandemic, especially azithromycin. To reach a conclusion regarding the main question, a detailed literature review method was used, including epidemiological and microbiological analyses, as well as studies detailing the use of azithromycin and its impacts on cases of microbiological resistance.
References
Acosta, R. G. & Vargas, C. M. (2018). Mecanismos de resistência bacteriana. Diagnóstico, 57(2), 82-86.
Almeida, I. D. (2021). Metodologia do trabalho científico. Ed. UFPE.
Anvisa (2024). Vendas de medicamentos industrializados e manipulados. https://app.powerbi.com/view?r=eyJrIjoiZjg0ZmFkYjItZmNmOC00M2M1LWI2YjQtMzU4OGMzNjA2NzcwIiwidCI6ImI2N2FmMjNmLWMzZjMtNGQzNS04MGM3LWI3MDg1ZjVlZGQ4MSJ9.
Bardin, L. (2011). Análise de conteúdo. Edições 70.
Fio, F. S.; Mattos Filho, T. R.. & Groppo, F. C. (2000). Resistência bacteriana. Revista Brasileira de Medicina, 57 (10), 1129-1140.
Freires, M. S. & Rodrigues Junior, O. M. (2022). Resistência bacteriana pelo uso indiscriminado da azitromicina frente a Covid-19: uma revisão integrativa. Research, Society And Development, 11 (1), 1-10.
Furlan, L. & Caramelli, B. (2021). The regrettable story of the “Covid Kit” and the “Early Treatment of Covid-19” in Brazil. The Lancet Regional Health - Americas, 4 (100089), 1-3.
Getahun, H.; Smith, I.; Trivedi, K.; Paulin, S. & Balkhy, H. H. (2020). Tackling antimicrobial resistance in the COVID-19 pandemic. Bulletin Of The World Health Organization, 98 (7), 442-442.
Hsu, J. (2020). How covid-19 is accelerating the threat of antimicrobial resistance. Bmj, 369 (1983), 2-2.
Langford, B. J.; So, M.; Raybardhan, S.; Leung, V.; Soucy, J. P. R.; Westwood, D.; Daneman, N. & Macfadden, D. R. (2021). Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clinical Microbiology And Infection, 27 (4), 520-531.
Leal, W. S.; Melo, D. N. A.; Silva, F. C. S; Nazaré, K. A.; Rodrigues, B. T. F.; Fernandes, E. L.; Araújo, M. E. S.; Martins, J. L. & Freitas, L. M. A. (2021). Análise da automedicação durante a pandemia do novo coronavírus: um olhar sobre a azitromicina. Revista Ibero-Americana de Humanidades, Ciências e Educação, 7(8), 580-592.
Lima, C. C.; Benjamin, S. C. C & Santos, R. F. S. (2017). Mecanismo de resistência bacteriana frente aos fármacos: uma revisão. Cuidarte Enferm, 11(1), 105-113.
Melo, J. R. R.; Duarte, E. C.; Moraes, M. V.; Fleck, K. & Arrais, P. S. D. (2021). Automedicação e uso indiscriminado de medicamentos durante a pandemia da COVID-19. Cadernos de Saúde Pública, 37(4), 1-5.
Micek, S. T.; Simmons, J.; Hampton, N.; Kollef, M. H. (2020). Characteristics and outcomes among a hospitalized patient cohort with Streptococcus pneumoniae infection. Medicine, 99(18)..
Miranda, I. C. S.; Vieira, R. M. S. & Souza, T.F . M. P. (2022). Consequências do uso inadequado de antibióticos: uma revisão de literatura. Research, Society And Development, 11(7), 1-7.
O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations; The review on antimicrobial resistance chaired.
Prodanov, C. C. & Freitas, E. C. (2013). Metodologia do trabalho científico: Métodos e Técnicas da Pesquisa e do Trabalho Acadêmico. Feevale.
Rawson, T. M.; Moore, L. S. P.; Zhu, N.; Ranganathan, N.; Sklimowska, K.; Gilchrist, M.; Satta, G.; Cooke. G. & Holmes, A. (20202). Bacterial and Fungal Coinfection in Individuals With Coronavirus: a rapid review to support covid-19 antimicrobial prescribing. Clinical Infectious Diseases, 71(9), 2459-2468.
Rodrigues, T. S.; Santos, A. M. R.; Lima, P. C.; Moura, M. E. B.; Goiano, P. D. O. L. & Fontinele, D. R. S. (2018). Resistência bacteriana à antibióticos na unidade de terapia intensiva: revisão integrativa. Revista Prevenção de Infecção e Saúde, 4 (7350), 1-17.
Rossato, L.; Negrão, F. J. & Simionatto, S. (2020).Could the COVID-19 pandemic aggravate antimicrobial resistance? American Journal Of Infection Control, 48 (9), 1129-1130.
Silva, C. C.; Carvalho, C. M. O.; Lima, D. C.; Costa, E. S.; Andrade, V. M. B.; Tenorio, B. M.; Britto, D. B. L. A. & Tenorio, F. C. A. M. (2021) Covid-19: aspectos da origem, fisiopatologia, imunologia e tratamento - uma revisão narrativa. Revista Eletrônica Acervo Saúde, 13(3), 1-8.
Silva, L. O. P.; Abrantes, J. A. & Nogueira, J. M. R. (2024). O uso indiscriminado de antimicrobianos durante a pandemia da COVID-19 como possível fator influenciador da resistência bacteriana em efluentes hospitalares no Brasil. Contribuciones A Las Ciencias Sociales, 17(3), 1-16.
Silva, L. O. P.; Alves, E. A. & Nogueira, J. M. R. (2022). Consequências do uso indiscriminado de antimicrobianos durante a pandemia de COVID-19 / Consequences of indiscriminate use of antimicrobials during the COVID-19 pandemic. Brazilian Journal Of Development, 8 (2), 10381-10397.
Silva, L. O. P. (2023). Aspectos gerais da covid-19 e as possíveis consequências do uso indiscriminado de antimicrobianos durante a pandemia no Brasil. [Dissertação de Mestrado, Fundação Oswaldo Cruz].
Soares, I. C. & Garcia, P. C. (2018). Resistência Bacteriana: a relação entre o consumo indiscriminado de antibióticos e o surgimento de superbactérias. Faculdade de Atenas, 6(1), 1-19.
Van Duin, D; Arias, C. A.; Komarow, L.; Chen, L.; Hanson, B. M.; Weston, G.; Cober, E.; Garner, O. B.; Jacob, J. T.; Satlin, M. J.; Fries, B. C.; Garcia-Diaz, J.; Doi, Y.; Dhar, S.; Kaye, K.S .; Earley, M.; Hujer, A. M.; Hujer, K. M.; Domitrovic, T. N. . . .& Bonomo, R. A. (2020). Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. The Lancet Infectious Diseases, 20 (6), 731-74.
Velosos, W. B. (2021). Determinação de antibióticos macrolídeos sobre eletrodo impresso de carbono modificado com carbon black super P em sistema BIA-AMP. [Dissertação de Mestrado, Universidade Federal do Maranhão].
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Gustavo José Vasco Pereira; Marcelo da Rosa Taciano; Maria Eduarda Medeiros Corrêa; Naiany Tomaz Aguiar; Vinicius Maiato Ramos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
